Literature DB >> 12767946

The CAG repeats in exon 1 of the androgen receptor gene are significantly longer in endometrial cancer patients.

Masahiro Sasaki1, Noriaki Sakuragi, Rajvir Dahiya.   

Abstract

Human androgen receptor (AR) gene contains polymorphic CAG repeats in the N-terminal domain that influence transcription efficiency. The CAG repeats encode a poly-glutamine tract, which has a length that is inversely and linearly related to AR activity. It has been observed that longer CAG repeats impose a lower transactivation activity on AR and have a decreased binding affinity for androgens. Androgens have an anti-proliferative effect on endometrial cells. We hypothesize that the length of CAG repeats on the AR gene can predict higher incidence of endometrial cancer. To test this hypothesis, the genetic distributions of CAG repeats on AR gene polymorphisms were investigated in endometrial cancer patients and healthy controls. Genotyping and a chi(2) test revealed that the distribution of CAG repeats was significantly different between the endometrial cancer patients and normal healthy controls (P<0.001). The endometrial cancer patients had longer alleles than normal healthy controls. The longer CAG repeats in the AR gene may cause a decrease of transactivation function in the receptor, weaken an anti-proliferative effect on uterine endometrial cells, and promote carcinogenesis of the uterine endometrial cells. The findings suggest that the CAG repeats in the AR gene may be important in the carcinogenesis of uterine endometrial cells.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12767946     DOI: 10.1016/s0006-291x(03)00883-0

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  7 in total

1.  Androgen receptor CAG and GGC polymorphisms in Mediterraneans: repeat dynamics and population relationships.

Authors:  Esther Esteban; Natalia Rodon; Marc Via; Emili Gonzalez-Perez; Josep Santamaria; Jean-Michel Dugoujon; Farha El Chennawi; Mohamed Melhaoui; Mohamed Cherkaoui; Giuseppe Vona; Nourdin Harich; Pedro Moral
Journal:  J Hum Genet       Date:  2005-12-20       Impact factor: 3.172

2.  Androgen receptor cytosine, adenine, guanine repeats, and haplotypes in relation to ovarian cancer risk.

Authors:  Kathryn L Terry; Immaculata De Vivo; Linda Titus-Ernstoff; Mei-Chiung Shih; Daniel W Cramer
Journal:  Cancer Res       Date:  2005-07-01       Impact factor: 12.701

Review 3.  Genetic polymorphisms and endometrial cancer risk.

Authors:  Larissa A Meyer; Shannon N Westin; Karen H Lu; Michael R Milam
Journal:  Expert Rev Anticancer Ther       Date:  2008-07       Impact factor: 4.512

4.  Genetic variation in the androgen receptor gene and endometrial cancer risk.

Authors:  Hannah P Yang; Montserrat Garcia-Closas; James V Lacey; Louise A Brinton; Jolanta Lissowska; Beta Peplonska; Stephen Chanock; Mia M Gaudet
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2009-02-03       Impact factor: 4.254

5.  Short androgen receptor poly-glutamine-promoted endometrial cancer is associated with benzo[a]pyrene-mediated aryl hydrocarbon receptor activation.

Authors:  Lumin Chen; Bo-Ying Bao; Wei-Chun Chang; Jason Yen-Ping Ho; Bi-Hua Cheng; Chung-Lin Wang; Qifeng Tang; Wei-Chung Cheng; Hui-Wen Chang; Yao-Ching Hung; Wen-Lung Ma
Journal:  J Cell Mol Med       Date:  2017-08-07       Impact factor: 5.310

6.  Androgen receptor CAG repeats, non-random X chromosome inactivation, and loss of heterozygosity at Xq25 in relation to breast cancer risk.

Authors:  Hui-Tzu Chen; Yao-Chung Wu; Shou-Tung Chen; Hsien-Chang Tsai; Yi-Chih Chien
Journal:  BMC Cancer       Date:  2014-03-01       Impact factor: 4.430

7.  FOXA1 promotes tumor cell proliferation through AR involving the Notch pathway in endometrial cancer.

Authors:  Meiting Qiu; Wei Bao; Jingyun Wang; Tingting Yang; Xiaoying He; Yun Liao; Xiaoping Wan
Journal:  BMC Cancer       Date:  2014-02-11       Impact factor: 4.430

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.